MiraLAX travel-size SKU approved
This article was originally published in The Tan Sheet
Executive Summary
FDA approves a supplemental new drug application for NeatPAX, a travel-size carton with 10 powder packets of MiraLAX (polyethylene glycol). The SNDA was submitted by Schering-Plough in April 2009, before its acquisition by Merck closed. FDA's May 5 1letter to the firm approves additional labeling for the laxative, including the statement "Sugar Free" for all stock-keeping units. Perrigo's launch of generic polyethylene glycol in 2009 has put pressure on Merck to innovate with MiraLAX or continue losing market share (2"The Tan Sheet" Nov. 9, 2009)
You may also be interested in...
Perrigo Strives To Stand Out Against Incoming Private Label Competition
Even as Perrigo products face the prospect of increasingly crowded segments, the company likes where it stands among private label competition
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.